MXPA03006985A - Variantes de ap1 amino oxidasa. - Google Patents

Variantes de ap1 amino oxidasa.

Info

Publication number
MXPA03006985A
MXPA03006985A MXPA03006985A MXPA03006985A MXPA03006985A MX PA03006985 A MXPA03006985 A MX PA03006985A MX PA03006985 A MXPA03006985 A MX PA03006985A MX PA03006985 A MXPA03006985 A MX PA03006985A MX PA03006985 A MXPA03006985 A MX PA03006985A
Authority
MX
Mexico
Prior art keywords
amine oxidase
oxidase variants
variants
amine
oxidase
Prior art date
Application number
MXPA03006985A
Other languages
English (en)
Inventor
Ranjini Chatterjee
Original Assignee
Maxygen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Inc filed Critical Maxygen Inc
Publication of MXPA03006985A publication Critical patent/MXPA03006985A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA03006985A 2001-02-06 2002-02-06 Variantes de ap1 amino oxidasa. MXPA03006985A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26691801P 2001-02-06 2001-02-06
US30032401P 2001-06-22 2001-06-22
PCT/US2002/003883 WO2002062964A2 (en) 2001-02-06 2002-02-06 Ap1 amine oxidase variants

Publications (1)

Publication Number Publication Date
MXPA03006985A true MXPA03006985A (es) 2004-01-29

Family

ID=29218627

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006985A MXPA03006985A (es) 2001-02-06 2002-02-06 Variantes de ap1 amino oxidasa.

Country Status (8)

Country Link
US (1) US20030056245A1 (es)
EP (1) EP1572861A4 (es)
AU (1) AU2002243922A1 (es)
BR (1) BR0207033A (es)
CA (1) CA2437189A1 (es)
HU (1) HUP0600671A3 (es)
MX (1) MXPA03006985A (es)
WO (1) WO2002062964A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206415D0 (en) * 2002-03-19 2002-05-01 Glaxo Group Ltd Deracemisation of amines
EP1576151A4 (en) * 2002-08-06 2006-05-17 Verdia Inc VARIANTS OF AMINE OXIDASE AP1
EP2308977B2 (en) 2004-04-30 2017-04-26 Dow AgroSciences LLC Novel herbicide resistance gene
US7639658B2 (en) * 2005-03-18 2009-12-29 Qualcomm Incorporated Efficient wireless transmission opportunity handoff
BRPI0618025B1 (pt) 2005-10-28 2016-12-27 Dow Agrosciences Llc método para controlar ervas daninhas em uma área, polinucleotídeo isolado, célula de planta e planta resistente a herbicida
JP7453745B2 (ja) * 2019-03-28 2024-03-21 株式会社ヤクルト本社 毒性タンパク質の活性を阻害するペプチドのスクリーニング方法及び毒性タンパク質の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4977099A (en) * 1998-07-15 2000-02-07 Curagen Corporation Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
HUP0202659A3 (en) * 1998-07-15 2004-10-28 Pioneer Hi Bred Int Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
JP2002526107A (ja) * 1998-10-07 2002-08-20 マキシジェン， インコーポレイテッド マイコトキシンの解毒のための核酸を生成するためのｄｎａシャッフリング

Also Published As

Publication number Publication date
BR0207033A (pt) 2006-11-14
HUP0600671A2 (en) 2008-03-28
US20030056245A1 (en) 2003-03-20
AU2002243922A1 (en) 2002-08-19
EP1572861A2 (en) 2005-09-14
WO2002062964A2 (en) 2002-08-15
HUP0600671A3 (en) 2010-03-29
CA2437189A1 (en) 2002-08-15
WO2002062964A3 (en) 2007-08-02
EP1572861A4 (en) 2008-03-05
AU2002243922A8 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
ZA200209011B (en) Electroactive catalysis.
MXPA03009558A (es) Compuestos novedosos.
AU2002357860A8 (en) Enzymes
MXPA01009037A (es) I-bet.
MXPA03007130A (es) Conjugados de peg de hgf-nk4.
MXPA03005286A (es) METODO Y APARATO PARA SUPERVISAR PULSACION DE INSTALACION DE ORDEnA.
MXPA03008139A (es) Fluoralcoxifenilsulfonilureas sustituidas.
MXPA03006985A (es) Variantes de ap1 amino oxidasa.
MXPA03009091A (es) Amidas novedosas del acido n-p-propargiloxifenetil-tioacetico.
GB0118156D0 (en) Leather production
HK1059781A1 (en) New phenylpiperazines.
EP1428891A4 (en) NEW GENE NEDL-1
AP2003002872A0 (en) Plant invigorator.
HK1050120A1 (en) Watchband.
ZA200307598B (en) Improved flotation.
AU2003304275A8 (en) Ap1 amine oxidase variants
GB2379929B (en) I. S. machine
HK1054889A1 (en) Sander.
GB0102946D0 (en) Enzyme
ZA200205516B (en) Process.
EP1482034A4 (en) NEW OXIDASE
GB0121840D0 (en) Modified enzyme
ZA200205117B (en) Golfing aid.
GB0105446D0 (en) S.s.h.p.s
MXPA01005709A (es) Panel-cimbra.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal